Key Lung Antibodies

Lung Cancer Antibodies


Lung cancers are the 2nd most diagnosed cancer in the United States, with about 13.5% of new cancer cases classified as lung, contributing 27.2% of cancer deaths yearly. As of 2011, there were approximately 402,000 people living with lung cancer in the United States. Those diagnosed with lung cancer have a 5 year survival rates of only 16.8%. Over the last 10 years, the rate of new lung cancer cases has fallen 1.5% per year, while the death rate has fallen 1.8% per year. Biocare Medical is proud to offer key lung antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD,


Biocare Clone

p40 (M)





Biocare Clone

Cytokeratin 7


Biocare Clone